Sarcoma News

NEW ORLEANS — David Polsky, MD, PhD, professor of dermatology and pathology at NYU School of Medicine and NYU Langone Medical Center, offers insights into advances in liquid biopsy.

The FDA granted priority review for olaratumab in combination with doxorubicin to treat patients with advanced soft tissue sarcoma who are not responsive to curative treatment with radiotherapy or surgery.

Yoga therapy is an integrative medicine technique that supplements the traditional treatment regimens patients with cancer undergo.

NEW ORLEANS — Kunle Odunsi, MD, PhD, FRCOG, FACOG, deputy director of Roswell Park Cancer Institute and executive director of the institute’s Center for Immunotherapy, spoke to HemOnc Today at the American Association for Cancer Research Annual Meeting about advances in the use of immunotherapy for cancer treatment.

The children of Hispanic mothers born outside the United States appeared to have reduced risk for several cancers, including glioma, astrocytoma, neuroblastoma and Wilms’ tumor, according to results of a population-based case–control study.

The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter published in JAMA Oncology.

Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment disorder — for up to 10 years, according to the results of a matched cohort study conducted in Sweden.

The FDA granted fast track designation to ADXS-HER2 for treatment of newly diagnosed, nonmetastatic, surgically resectable osteosarcoma, according to a press release from the agent’s manufacturer.

Molecular genetic testing should be mandatory during the diagnosis of sarcoma, even when patients have been diagnosed histologically by an expert pathologist, according to the researchers of a prospective observational study.

The overall health-related quality of life of young adult survivors of childhood cancer resembled that of middle-aged adults, according to a brief communication report published in Journal of the National Cancer Institute.